EUVIMEDEUVIMED entdecken
Open Access

Assessing Potential Benefit of Stroke Prophylaxis Therapy in Atrial Fibrillation and Atrial Flutter Using a Novel Competing Risk Scoring Tool

Anthony J Mazzella iD, Thomas C Daubert iD, Wanting Jin iD, Quefeng Li iD, Lindsey Rosman iD, Anil K Gehi iD

Journal of the American Heart Association · 2026

DOI: 10.1161/jaha.125.044151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Anthony J Mazzella und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine University of North Carolina at Chapel Hill Chapel Hill NC USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Atrial Flutter, Stroke, Anticoagulants. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The competing risk of nonstroke mortality may limit the potential benefit of stroke prophylaxis therapy in patients with atrial fibrillation or atrial flutter AF.

Methods

Using a Medicare 20% sample, we identified a cohort of beneficiaries diagnosed with atrial fibrillation or atrial flutter from 2006 to 2019 using International Classification of Diseases, Ninth Revision ( ICD‐9 ) and Tenth Revision ( ICD‐10 ) codes. Fine and Gray regression analysis determined the hazard of stroke with a competing risk of nonstroke mortality, and Cox proportional hazard analysis determined risk of nonstroke mortality. A scoring tool stratified patients into low or high potential benefit for thromboembolic prophylaxis.

Results

Among a total of 1 883 759 Medicare beneficiaries, 330 136 patients were included with median age of 79.7 years. 54% of patients had prior bleeding episodes. The median CHA 2 DS 2 ‐VASc score was 5. Of these patients, 211 791 (64%) died and 77 717 (24%) experienced an embolic stroke over median follow‐up of 7.3 years. In the high potential benefit group (26.1%), the risk of stroke was much higher than the risk of nonstroke mortality at 1 year (12.2% versus 7.1%); 3 years (22.7% versus 16.9%); 5 years (31.9% versus 26.1%). In the low potential benefit group (73.9%), the risk of stroke was much lower than the risk of nonstroke mortality at 1 year (11.5% versus 39.2%); 3 years (23.2 versus 57.2%); and 5 years (34.3% versus 69.4%).

Conclusions

We propose a scoring tool to identify the potential benefit of thromboembolic prophylaxis therapy in older patients diagnosed with atrial fibrillation or atrial flutter. This tool can be used in shared decision‐making settings. Further studies to improve and validate this scoring tool are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAtrial FlutterStrokeAnticoagulantsHumansAgedMaleFemaleRisk AssessmentRisk FactorsUnited StatesAged, 80 and overRetrospective StudiesMedicareTreatment Outcome

Stichwörter der Autor:innen

anticoagulationatrial fibrillationcompeting riskmortalitythromboembolic prophylaxis

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine University of North Carolina at Chapel Hill Chapel Hill NC USA.
  • Department of Biostatistics University of North Carolina Gillings School of Global Public Health Chapel Hill NC USA.

ORCID-Profile: Anthony J Mazzella, Thomas C Daubert, Wanting Jin, Quefeng Li, Lindsey Rosman, Anil K Gehi

Zitieren

APA

Mazzella, A. J., Daubert, T. C., Jin, W., Li, Q., Rosman, L., & Gehi, A. K. (2026). Assessing Potential Benefit of Stroke Prophylaxis Therapy in Atrial Fibrillation and Atrial Flutter Using a Novel Competing Risk Scoring Tool. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.044151

Vancouver

Mazzella AJ, Daubert TC, Jin W, Li Q, Rosman L, Gehi AK. Assessing Potential Benefit of Stroke Prophylaxis Therapy in Atrial Fibrillation and Atrial Flutter Using a Novel Competing Risk Scoring Tool. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.044151

BibTeX
@article{Mazzella2026,
  author = {Mazzella, Anthony J and Daubert, Thomas C and Jin, Wanting and Li, Quefeng and Rosman, Lindsey and Gehi, Anil K},
  title = {Assessing Potential Benefit of Stroke Prophylaxis Therapy in Atrial Fibrillation and Atrial Flutter Using a Novel Competing Risk Scoring Tool},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.044151}
}
Kostenlos starten →